Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro DiagnosticsRespiratory

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1490832

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1490832

Respiratory Diagnostics Market - Global Respiratory Diagnostics Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 -

PUBLISHED:
PAGES: 210 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

Description

Table of Contents

The respiratory diagnostics market is set for significant growth, with its size anticipated to soar from US$8.5 billion in 2022 to US$14.19 billion by the end of 2030. This market is projected to achieve a compound annual growth rate (CAGR) of 7.6% from 2023 to 2030, driven by several factors including the rising prevalence of respiratory disorders and advancements in diagnostic technologies.

Market Overview

The global respiratory diagnostics market is experiencing rapid expansion, fueled by the increasing prevalence of respiratory disorders such as pneumonia, tuberculosis, and chronic obstructive pulmonary disease (COPD). Enhanced research and development (R&D) investments by key players in the diagnostics sector further bolster this market's growth. In 2022, the instruments and devices segment led the market, driven by the continuous demand for diagnostic tools in hospitals, point-of-care settings, and laboratories.

Key Market Drivers

1. Rising Prevalence of Respiratory Disorders: The growing incidence of respiratory conditions, including asthma and lung cancer, is a significant market driver. Technological advancements in diagnostic procedures have led to more accurate, mobile, and affordable testing solutions.

2. Technological Advancements: Rapid technological progress in respiratory diagnostics has enhanced the accuracy, mobility, and cost-efficiency of diagnostic tests, significantly impacting the market.

3. Government and NGO Initiatives: Efforts by governmental and non-governmental organizations to provide quality healthcare facilities are fueling market growth. Improved R&D, a growing elderly population, and rising pollution levels are additional contributing factors.

Market Challenges

1. Insufficient Medical Reimbursement Policies: Limited availability of medical reimbursement policies can hinder market growth, especially in regions where diagnostic procedures are costly. The lack of favorable reimbursement options can act as a growth inhibitor for the respiratory diagnostics market.

2. High Costs of Research and Product Innovation: The significant expenses associated with product development and innovation pose challenges for market participants. Fluctuating raw material prices, transportation costs, and geopolitical uncertainties add to the complexity.

Emerging Trends and Opportunities

1. Growing Healthcare Infrastructure: Investments in healthcare infrastructure, particularly in developing regions, are expected to drive market growth. Governments and international healthcare organizations are working towards providing high-quality medical care, further fueling demand for respiratory diagnostics.

2. Technological Innovations: The adoption of electronic inhalers, monitoring devices, and other innovative diagnostic tools is boosting market growth. Increased awareness about treatment options in both developed and developing countries supports this trend.

3. Rising Demand for Point-of-Care Diagnostic Devices: The point-of-care segment is gaining traction due to increased funding, the rising prevalence of target diseases, and the necessity to manage the COVID-19 outbreak. Digital technology integration is expected to significantly impact the expansion of point-of-care solutions.

Regional Market Leaders

North America: This region is anticipated to hold the largest share of the global respiratory diagnostics market, driven by the high prevalence of chronic respiratory diseases and a significant elderly population. Rapid climate change, rising pollution levels, and advanced healthcare systems contribute to North America's market dominance.

Asia Pacific: The Asia Pacific region represents a lucrative market for respiratory diagnostics, with growing healthcare infrastructure and increasing consumer awareness driving demand. The rise in respiratory disorders in this region is expected to propel market growth, supported by substantial investments from key players.

Competitive Analysis

  • Medtronic
  • COSMED SRL
  • GENERAL ELECTRIC COMPANY
  • Koninklijke Philips N.V.
  • Hoffmann-La Roche Ltd
  • NIHON KOHDEN CORPORATION
  • GC Diagnostics Corporation
  • Masimo
  • Dragerwerk AG & Co. KGaA
  • Bio-Rad Laboratories Inc.
  • bioMerieux SA
  • Carestream Health
  • Abbott
  • Johnson & Johnson Services Inc.
  • Thermo Fisher Scientific Inc.

Global Respiratory Diagnostic Market is Segmented as:

By Product:

  • Instruments
  • Assays and Reagents

By Test Type:

  • Spirometry
  • Peak Flow Measurement
  • Pulse Oximetry
  • Arterial Blood Gas (ABG) Test
  • Chest X-ray
  • CT (Computed Tomography) Scan
  • MRI (Magnetic Resonance Imaging)
  • Bronchoscopy
  • Pulmonary Function Tests (PFTs)
  • Methacholine Challenge Test
  • Nasal Smear or Swab

By Disease:

  • Chronic Obstructive Pulmonary Disease
  • Lung Cancer
  • Asthma
  • Tuberculosis
  • Other Disease

By End User:

  • Hospitals/Clinical Laboratories
  • Physician Offices
  • Reference Laboratories
  • Other End Users

By Geographic Coverage:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Turkey
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Egypt
    • Nigeria
    • Rest of Middle East & Africa
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Respiratory Diagnostics Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2022
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. Covid-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Respiratory Diagnostics Market Outlook, 2018 - 2030

  • 3.1. Global Respiratory Diagnostics Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
    • 3.1.1. Key Highlights
      • 3.1.1.1. Instruments
      • 3.1.1.2. Assays and Reagents
  • 3.2. Global Respiratory Diagnostics Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2030
    • 3.2.1. Key Highlights
      • 3.2.1.1. Spirometry
      • 3.2.1.2. Peak Flow Measurement
      • 3.2.1.3. Pulse Oximetry
      • 3.2.1.4. Arterial Blood Gas (ABG) Test
      • 3.2.1.5. Chest X-ray
      • 3.2.1.6. CT (Computed Tomography) Scan
      • 3.2.1.7. MRI (Magnetic Resonance Imaging)
      • 3.2.1.8. Bronchoscopy
      • 3.2.1.9. Pulmonary Function Tests (PFTs)
      • 3.2.1.10. Methacholine Challenge Test
      • 3.2.1.11. Nasal Smear or Swab
  • 3.3. Global Respiratory Diagnostics Market Outlook, by Disease, Value (US$ Bn), 2018 - 2030
    • 3.3.1. Key Highlights
      • 3.3.1.1. Chronic Obstructive Pulmonary Disease
      • 3.3.1.2. Lung Cancer
      • 3.3.1.3. Asthma
      • 3.3.1.4. Tuberculosis
      • 3.3.1.5. Other Disease
  • 3.4. Global Respiratory Diagnostics Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
    • 3.4.1. Key Highlights Snacks
      • 3.4.1.1. Hospitals/Clinical Laboratories
      • 3.4.1.2. Physician Offices
      • 3.4.1.3. Reference Laboratories
      • 3.4.1.4. Other End Users
  • 3.5. Global Respiratory Diagnostics Market Outlook, by Region, Value (US$ Bn), 2018 - 2030
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America Respiratory Diagnostics Market Outlook, 2018 - 2030

  • 4.1. North America Respiratory Diagnostics Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
    • 4.1.1. Key Highlights
      • 4.1.1.1. Instruments
      • 4.1.1.2. Assays and Reagents
  • 4.2. North America Respiratory Diagnostics Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2030
    • 4.2.1. Key Highlights
      • 4.2.1.1. Spirometry
      • 4.2.1.2. Peak Flow Measurement
      • 4.2.1.3. Pulse Oximetry
      • 4.2.1.4. Arterial Blood Gas (ABG) Test
      • 4.2.1.5. Chest X-ray
      • 4.2.1.6. CT (Computed Tomography) Scan
      • 4.2.1.7. MRI (Magnetic Resonance Imaging)
      • 4.2.1.8. Bronchoscopy
      • 4.2.1.9. Pulmonary Function Tests (PFTs)
      • 4.2.1.10. Methacholine Challenge Test
      • 4.2.1.11. Nasal Smear or Swab
  • 4.3. North America Respiratory Diagnostics Market Outlook, by Disease, Value (US$ Bn), 2018 - 2030
    • 4.3.1. Key Highlights
      • 4.3.1.1. Chronic Obstructive Pulmonary Disease
      • 4.3.1.2. Lung Cancer
      • 4.3.1.3. Asthma
      • 4.3.1.4. Tuberculosis
      • 4.3.1.5. Other Disease
  • 4.4. North America Respiratory Diagnostics Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
    • 4.4.1. Key Highlights
      • 4.4.1.1. Hospitals/Clinical Laboratories
      • 4.4.1.2. Physician Offices
      • 4.4.1.3. Reference Laboratories
      • 4.4.1.4. Other End Users
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis
  • 4.5. North America Respiratory Diagnostics Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. Respiratory Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
      • 4.5.1.2. U.S. Respiratory Diagnostics Market by Test Type, Value (US$ Bn), 2018 - 2030
      • 4.5.1.3. U.S. Respiratory Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2030
      • 4.5.1.4. U.S. Respiratory Diagnostics Market by End User, Value (US$ Bn), 2018 - 2030
      • 4.5.1.5. Canada Respiratory Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
      • 4.5.1.6. Canada Respiratory Diagnostics Market by Test Type, Value (US$ Bn), 2018 - 2030
      • 4.5.1.7. Canada Respiratory Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2030
      • 4.5.1.8. Canada Respiratory Diagnostics Market by End User, Value (US$ Bn), 2018 - 2030
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Respiratory Diagnostics Market Outlook, 2018 - 2030

  • 5.1. Europe Respiratory Diagnostics Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
    • 5.1.1. Key Highlights
      • 5.1.1.1. Instruments
      • 5.1.1.2. Assays and Reagents
  • 5.2. Europe Respiratory Diagnostics Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2030
    • 5.2.1. Key Highlights
      • 5.2.1.1. Spirometry
      • 5.2.1.2. Peak Flow Measurement
      • 5.2.1.3. Pulse Oximetry
      • 5.2.1.4. Arterial Blood Gas (ABG) Test
      • 5.2.1.5. Chest X-ray
      • 5.2.1.6. CT (Computed Tomography) Scan
      • 5.2.1.7. MRI (Magnetic Resonance Imaging)
      • 5.2.1.8. Bronchoscopy
      • 5.2.1.9. Pulmonary Function Tests (PFTs)
      • 5.2.1.10. Methacholine Challenge Test
      • 5.2.1.11. Nasal Smear or Swab
  • 5.3. Europe Respiratory Diagnostics Market Outlook, by Disease, Value (US$ Bn), 2018 - 2030
    • 5.3.1. Key Highlights
      • 5.3.1.1. Chronic Obstructive Pulmonary Disease
      • 5.3.1.2. Lung Cancer
      • 5.3.1.3. Asthma
      • 5.3.1.4. Tuberculosis
      • 5.3.1.5. Other Disease
  • 5.4. Europe Respiratory Diagnostics Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
    • 5.4.1. Key Highlights
      • 5.4.1.1. Hospitals/Clinical Laboratories
      • 5.4.1.2. Physician Offices
      • 5.4.1.3. Reference Laboratories
      • 5.4.1.4. Other End Users
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis
  • 5.5. Europe Respiratory Diagnostics Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany Respiratory Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
      • 5.5.1.2. Germany Respiratory Diagnostics Market by Test Type, Value (US$ Bn), 2018 - 2030
      • 5.5.1.3. Germany Respiratory Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2030
      • 5.5.1.4. Germany Respiratory Diagnostics Market by End User, Value (US$ Bn), 2018 - 2030
      • 5.5.1.5. U.K. Respiratory Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
      • 5.5.1.6. U.K. Respiratory Diagnostics Market by Test Type, Value (US$ Bn), 2018 - 2030
      • 5.5.1.7. U.K. Respiratory Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2030
      • 5.5.1.8. U.K. Respiratory Diagnostics Market by End User, Value (US$ Bn), 2018 - 2030
      • 5.5.1.9. France Respiratory Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
      • 5.5.1.10. France Respiratory Diagnostics Market by Test Type, Value (US$ Bn), 2018 - 2030
      • 5.5.1.11. France Respiratory Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2030
      • 5.5.1.12. France Respiratory Diagnostics Market by End User, Value (US$ Bn), 2018 - 2030
      • 5.5.1.13. Italy Respiratory Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
      • 5.5.1.14. Italy Respiratory Diagnostics Market by Test Type, Value (US$ Bn), 2018 - 2030
      • 5.5.1.15. Italy Respiratory Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2030
      • 5.5.1.16. Italy Respiratory Diagnostics Market by End User, Value (US$ Bn), 2018 - 2030
      • 5.5.1.17. Turkey Respiratory Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
      • 5.5.1.18. Turkey Respiratory Diagnostics Market by Test Type, Value (US$ Bn), 2018 - 2030
      • 5.5.1.19. Turkey Respiratory Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2030
      • 5.5.1.20. Turkey Respiratory Diagnostics Market by End User, Value (US$ Bn), 2018 - 2030
      • 5.5.1.21. Russia Respiratory Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
      • 5.5.1.22. Russia Respiratory Diagnostics Market by Test Type, Value (US$ Bn), 2018 - 2030
      • 5.5.1.23. Russia Respiratory Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2030
      • 5.5.1.24. Russia Respiratory Diagnostics Market by End User, Value (US$ Bn), 2018 - 2030
      • 5.5.1.25. Rest of Europe Respiratory Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
      • 5.5.1.26. Rest of Europe Respiratory Diagnostics Market by Test Type, Value (US$ Bn), 2018 - 2030
      • 5.5.1.27. Rest of Europe Respiratory Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2030
      • 5.5.1.28. Rest of Europe Respiratory Diagnostics Market by End User, Value (US$ Bn), 2018 - 2030
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Respiratory Diagnostics Market Outlook, 2018 - 2030

  • 6.1. Asia Pacific Respiratory Diagnostics Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
    • 6.1.1. Key Highlights
      • 6.1.1.1. Instruments
      • 6.1.1.2. Assays and Reagents
  • 6.2. Asia Pacific Respiratory Diagnostics Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2030
    • 6.2.1. Key Highlights
      • 6.2.1.1. Spirometry
      • 6.2.1.2. Peak Flow Measurement
      • 6.2.1.3. Pulse Oximetry
      • 6.2.1.4. Arterial Blood Gas (ABG) Test
      • 6.2.1.5. Chest X-ray
      • 6.2.1.6. CT (Computed Tomography) Scan
      • 6.2.1.7. MRI (Magnetic Resonance Imaging)
      • 6.2.1.8. Bronchoscopy
      • 6.2.1.9. Pulmonary Function Tests (PFTs)
      • 6.2.1.10. Methacholine Challenge Test
      • 6.2.1.11. Nasal Smear or Swab
  • 6.3. Asia Pacific Respiratory Diagnostics Market Outlook, by Disease, Value (US$ Bn), 2018 - 2030
    • 6.3.1. Key Highlights
      • 6.3.1.1. Chronic Obstructive Pulmonary Disease
      • 6.3.1.2. Lung Cancer
      • 6.3.1.3. Asthma
      • 6.3.1.4. Tuberculosis
      • 6.3.1.5. Other Disease
  • 6.4. Asia Pacific Respiratory Diagnostics Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
    • 6.4.1. Key Highlights
      • 6.4.1.1. Hospitals/Clinical Laboratories
      • 6.4.1.2. Physician Offices
      • 6.4.1.3. Reference Laboratories
      • 6.4.1.4. Other End Users
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis
  • 6.5. Asia Pacific Respiratory Diagnostics Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
    • 6.5.1. Key Highlights
      • 6.5.1.1. China Respiratory Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
      • 6.5.1.2. China Respiratory Diagnostics Market by Test Type, Value (US$ Bn), 2018 - 2030
      • 6.5.1.3. China Respiratory Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2030
      • 6.5.1.4. China Respiratory Diagnostics Market by End User, Value (US$ Bn), 2018 - 2030
      • 6.5.1.5. Japan Respiratory Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
      • 6.5.1.6. Japan Respiratory Diagnostics Market by Test Type, Value (US$ Bn), 2018 - 2030
      • 6.5.1.7. Japan Respiratory Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2030
      • 6.5.1.8. Japan Respiratory Diagnostics Market by End User, Value (US$ Bn), 2018 - 2030
      • 6.5.1.9. South Korea Respiratory Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
      • 6.5.1.10. South Korea Respiratory Diagnostics Market by Test Type, Value (US$ Bn), 2018 - 2030
      • 6.5.1.11. South Korea Respiratory Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2030
      • 6.5.1.12. South Korea Respiratory Diagnostics Market by End User, Value (US$ Bn), 2018 - 2030
      • 6.5.1.13. India Respiratory Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
      • 6.5.1.14. India Respiratory Diagnostics Market by Test Type, Value (US$ Bn), 2018 - 2030
      • 6.5.1.15. India Respiratory Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2030
      • 6.5.1.16. India Respiratory Diagnostics Market by End User, Value (US$ Bn), 2018 - 2030
      • 6.5.1.17. Southeast Asia Respiratory Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
      • 6.5.1.18. Southeast Asia Respiratory Diagnostics Market by Test Type, Value (US$ Bn), 2018 - 2030
      • 6.5.1.19. Southeast Asia Respiratory Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2030
      • 6.5.1.20. Southeast Asia Respiratory Diagnostics Market by End User, Value (US$ Bn), 2018 - 2030
      • 6.5.1.21. Rest of Asia Pacific Respiratory Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
      • 6.5.1.22. Rest of Asia Pacific Respiratory Diagnostics Market by Test Type, Value (US$ Bn), 2018 - 2030
      • 6.5.1.23. Rest of Asia Pacific Respiratory Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2030
      • 6.5.1.24. Rest of Asia Pacific Respiratory Diagnostics Market by End User, Value (US$ Bn), 2018 - 2030
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Respiratory Diagnostics Market Outlook, 2018 - 2030

  • 7.1. Latin America Respiratory Diagnostics Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
    • 7.1.1. Key Highlights
      • 7.1.1.1. Instruments
      • 7.1.1.2. Assays and Reagents
  • 7.2. Latin America Respiratory Diagnostics Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2030
    • 7.2.1. Key Highlights
      • 7.2.1.1. Spirometry
      • 7.2.1.2. Peak Flow Measurement
      • 7.2.1.3. Pulse Oximetry
      • 7.2.1.4. Arterial Blood Gas (ABG) Test
      • 7.2.1.5. Chest X-ray
      • 7.2.1.6. CT (Computed Tomography) Scan
      • 7.2.1.7. MRI (Magnetic Resonance Imaging)
      • 7.2.1.8. Bronchoscopy
      • 7.2.1.9. Pulmonary Function Tests (PFTs)
      • 7.2.1.10. Methacholine Challenge Test
      • 7.2.1.11. Nasal Smear or Swab
  • 7.3. Latin America Respiratory Diagnostics Market Outlook, by Disease, Value (US$ Bn), 2018 - 2030
    • 7.3.1. Key Highlights
      • 7.3.1.1. Chronic Obstructive Pulmonary Disease
      • 7.3.1.2. Lung Cancer
      • 7.3.1.3. Asthma
      • 7.3.1.4. Tuberculosis
      • 7.3.1.5. Other Disease
  • 7.4. Latin America Respiratory Diagnostics Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
    • 7.4.1. Key Highlights
      • 7.4.1.1. Hospitals/Clinical Laboratories
      • 7.4.1.2. Physician Offices
      • 7.4.1.3. Reference Laboratories
      • 7.4.1.4. Other End Users
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis
  • 7.5. Latin America Respiratory Diagnostics Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil Respiratory Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
      • 7.5.1.2. Brazil Respiratory Diagnostics Market by Test Type, Value (US$ Bn), 2018 - 2030
      • 7.5.1.3. Brazil Respiratory Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2030
      • 7.5.1.4. Brazil Respiratory Diagnostics Market by End User, Value (US$ Bn), 2018 - 2030
      • 7.5.1.5. Mexico Respiratory Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
      • 7.5.1.6. Mexico Respiratory Diagnostics Market by Test Type, Value (US$ Bn), 2018 - 2030
      • 7.5.1.7. Mexico Respiratory Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2030
      • 7.5.1.8. Mexico Respiratory Diagnostics Market by End User, Value (US$ Bn), 2018 - 2030
      • 7.5.1.9. Argentina Respiratory Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
      • 7.5.1.10. Argentina Respiratory Diagnostics Market by Test Type, Value (US$ Bn), 2018 - 2030
      • 7.5.1.11. Argentina Respiratory Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2030
      • 7.5.1.12. Argentina Respiratory Diagnostics Market by End User, Value (US$ Bn), 2018 - 2030
      • 7.5.1.13. Rest of Latin America Respiratory Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
      • 7.5.1.14. Rest of Latin America Respiratory Diagnostics Market by Test Type, Value (US$ Bn), 2018 - 2030
      • 7.5.1.15. Rest of Latin America Respiratory Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2030
      • 7.5.1.16. Rest of Latin America Respiratory Diagnostics Market by End User, Value (US$ Bn), 2018 - 2030
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Respiratory Diagnostics Market Outlook, 2018 - 2030

  • 8.1. Middle East & Africa Respiratory Diagnostics Market Outlook, by Product, Value (US$ Bn), 2018 - 2030
    • 8.1.1. Key Highlights
      • 8.1.1.1. Instruments
      • 8.1.1.2. Assays and Reagents
  • 8.2. Middle East & Africa Respiratory Diagnostics Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2030
    • 8.2.1. Key Highlights
      • 8.2.1.1. Spirometry
      • 8.2.1.2. Peak Flow Measurement
      • 8.2.1.3. Pulse Oximetry
      • 8.2.1.4. Arterial Blood Gas (ABG) Test
      • 8.2.1.5. Chest X-ray
      • 8.2.1.6. CT (Computed Tomography) Scan
      • 8.2.1.7. MRI (Magnetic Resonance Imaging)
      • 8.2.1.8. Bronchoscopy
      • 8.2.1.9. Pulmonary Function Tests (PFTs)
      • 8.2.1.10. Methacholine Challenge Test
      • 8.2.1.11. Nasal Smear or Swab
  • 8.3. Middle East & Africa Respiratory Diagnostics Market Outlook, by Disease, Value (US$ Bn), 2018 - 2030
    • 8.3.1. Key Highlights
      • 8.3.1.1. Chronic Obstructive Pulmonary Disease
      • 8.3.1.2. Lung Cancer
      • 8.3.1.3. Asthma
      • 8.3.1.4. Tuberculosis
      • 8.3.1.5. Other Disease
  • 8.4. Middle East & Africa Respiratory Diagnostics Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
    • 8.4.1. Key Highlights
      • 8.4.1.1. Hospitals/Clinical Laboratories
      • 8.4.1.2. Physician Offices
      • 8.4.1.3. Reference Laboratories
      • 8.4.1.4. Other End Users
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis
  • 8.5. Middle East & Africa Respiratory Diagnostics Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC Respiratory Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
      • 8.5.1.2. GCC Respiratory Diagnostics Market by Test Type, Value (US$ Bn), 2018 - 2030
      • 8.5.1.3. GCC Respiratory Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2030
      • 8.5.1.4. GCC Respiratory Diagnostics Market by End User, Value (US$ Bn), 2018 - 2030
      • 8.5.1.5. South Africa Respiratory Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
      • 8.5.1.6. South Africa Respiratory Diagnostics Market by Test Type, Value (US$ Bn), 2018 - 2030
      • 8.5.1.7. South Africa Respiratory Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2030
      • 8.5.1.8. South Africa Respiratory Diagnostics Market by End User, Value (US$ Bn), 2018 - 2030
      • 8.5.1.9. Egypt Respiratory Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
      • 8.5.1.10. Egypt Respiratory Diagnostics Market by Test Type, Value (US$ Bn), 2018 - 2030
      • 8.5.1.11. Egypt Respiratory Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2030
      • 8.5.1.12. Egypt Respiratory Diagnostics Market by End User, Value (US$ Bn), 2018 - 2030
      • 8.5.1.13. Nigeria Respiratory Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
      • 8.5.1.14. Nigeria Respiratory Diagnostics Market by Test Type, Value (US$ Bn), 2018 - 2030
      • 8.5.1.15. Nigeria Respiratory Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2030
      • 8.5.1.16. Nigeria Respiratory Diagnostics Market by End User, Value (US$ Bn), 2018 - 2030
      • 8.5.1.17. Rest of Middle East & Africa Respiratory Diagnostics Market by Product, Value (US$ Bn), 2018 - 2030
      • 8.5.1.18. Rest of Middle East & Africa Respiratory Diagnostics Market by Test Type, Value (US$ Bn), 2018 - 2030
      • 8.5.1.19. Rest of Middle East & Africa Respiratory Diagnostics Market by Disease, Value (US$ Bn), 2018 - 2030
      • 8.5.1.20. Rest of Middle East & Africa Respiratory Diagnostics Market by End User, Value (US$ Bn), 2018 - 2030
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Capacity vs Application Heatmap
  • 9.2. Manufacturer vs Application Heatmap
  • 9.3. Company Market Share Analysis, 2022
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Medtronic (Ireland)
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. COSMED srl (Italy)
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Product Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. GENERAL ELECTRIC COMPANY (US)
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Product Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. Koninklijke Philips N.V. (Netherlands)
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Product Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. Hoffmann-La Roche Ltd (Switzerland)
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Product Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. NIHON KOHDEN CORPORATION (Japan)
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Product Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. GC Diagnostics Corporation (South Korea)
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Product Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. Masimo (US)
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Product Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
    • 9.5.9. Dragerwerk AG & Co. KGaA (Germany)
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Product Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. Bio-Rad Laboratories Inc. (US)
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Product Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development
    • 9.5.11. bioMerieux SA (France)
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Product Portfolio
      • 9.5.11.3. Financial Overview
      • 9.5.11.4. Business Strategies and Development
    • 9.5.12. Carestream Health (US)
      • 9.5.12.1. Company Overview
      • 9.5.12.2. Product Portfolio
      • 9.5.12.3. Financial Overview
      • 9.5.12.4. Business Strategies and Development
    • 9.5.13. Abbott (US)
      • 9.5.13.1. Company Overview
      • 9.5.13.2. Product Portfolio
      • 9.5.13.3. Financial Overview
      • 9.5.13.4. Business Strategies and Development
    • 9.5.14. Johnson & Johnson Services Inc. (US)
      • 9.5.14.1. Company Overview
      • 9.5.14.2. Product Portfolio
      • 9.5.14.3. Financial Overview
      • 9.5.14.4. Business Strategies and Development
    • 9.5.15. Thermo Fisher Scientific Inc. (US)
      • 9.5.15.1. Company Overview
      • 9.5.15.2. Product Portfolio
      • 9.5.15.3. Financial Overview
      • 9.5.15.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!